The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Open accessAbstract
A handful of tumor-derived cell lines form the mainstay of cancer therapeutic development, yielding drugs with an impact typically measured as months to disease progression. To develop more effective breast cancer therapeutics and more readily understand their clinical impact, we constructed a functional metabolic portrait of 46 independently derived breast cell lines. Our analysis of glutamine uptake and dependence identified a subset of triple-negative samples that are glutamine auxotrophs. Ambient glutamine indirectly supports environmental cystine acquisition via the xCT antiporter, which is expressed on one-third of triple-negative tumors in vivo. xCT inhibition with the clinically approved anti-inflammatory sulfasalazine decreases tumor growth, revealing a therapeutic target in breast tumors of poorest prognosis and a lead compound for rapid, effective drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“implying that xc− may constitute a therapeutic target in this setting [553, 554].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [553]
In the citing paper
“the pronounced addiction of triple-negative breast carcinoma to glutamine relates (at least in part) to its ability to drive cystine uptake via xc−, implying that xc− may constitute a therapeutic target in this setting [553, 554].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [553]
In the citing paper
“Consistent with this observation, glutamine starvation has been associated with impaired uptake of cystine through xCT and decreased intracellular glutathione levels62.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Self-citationFatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O. A., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,290
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–575 of 575
Chen, C., Yang, L., Li, M., Gao, L., Qin, X., Du, G., & Zhou, Y. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad050 · Cited by 2
Targeting xCT-mediated glutamate release normalizes tumor angiogenesis in the brainPreprint
Fan, Z., Broggini, T., Yakubov, E., Sehm, T., Schürmann, S., Meyer, E. P., Stanković, N. D., Schmidt, M. H. H., Stampanoni, M., Czabanka, M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/134924 · Cited by 3
Wang, J. S., Strauss, R., Bártek, J., & Rudd, S. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.19.604261 · Cited by 2
Anticancer Effects of the Trivalent Organoarsenical 2-Amino-4-(dihydroxyarsinoyl) Butanoate
Venkadesh, S., Yoshinaga-Sakurai, K., & Rosen, B. P. (2024) · Organometallics · doi:10.1021/acs.organomet.4c00082 · Cited by 1
Zhu, M., Wang, C., & Song, D. (2025) · iScience · doi:10.1016/j.isci.2025.112405 · Cited by 2
Qin, M., Zhu, M., Chen, Y. A., Zeng, Q., & Wu, W. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152389 · Cited by 1
Mitochondria ATP Pro‐Ferroptosis by Adjusting the Conversion of PUFA to PUFA‐PLs
Xia, C., Gao, L., Min, J., & Fu, C. (2025) · MedComm – Oncology · doi:10.1002/mog2.70038 · Cited by 1
Nutrient-transporter driven cytotoxic potential: an emerging nanotherapeutic approach
Dighe, S., Manchanda, N., Sharma, S., & Jain, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104478 · Cited by 1
Zhang, Y., Cui, X., Du, J., Cui, G., Ling, Y., & Tang, C. (2025) · iScience · doi:10.1016/j.isci.2025.113718 · Cited by 1
Li, K., Chen, X., Shu, G., Yu, J., Chen, Y., Guo, X., Chen, M., Wu, F., Su, J., & Ji, J. (2026) · Advanced Interventional Materials · doi:10.1016/j.advim.2025.100007 · Cited by 1
Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer
Su, Y., Liu, X., Yu, Y., Chen, X., Shi, L., Du, Z., Mao, Y., & Yin, F. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020226 · Cited by 1
Wang, Y., Li, J., Yan, Y., & Sun, L. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.106983 · Cited by 1
Wang, S., Chang, C., Xu, R., Wang, L., Gao, B., Yan, Y., Gong, Y., & Li, Y. (2026) · Cells · doi:10.3390/cells15070589 · Cited by 1
Syed, M. M., Rajasekaran, D., Sennoune, S. R., Sharker, T., Sanchez, O., Jurek, M. K., Kou, L., Chen, R., Ganapathy, V., & Bhutia, Y. D. (2026) · Biochemical Journal · doi:10.1042/bcj20250155 · Cited by 2
Du, J., Guo, K., Wang, C., Zhang, X., Yang, Y., Chu, T., Yang, D., Zheng, D., & Ma, W. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109901 · Cited by 1
Ma, H., Lu, H., Zhang, Z., Wang, J., Zhao, Q., Ding, Y., Wang, X., Zhang, W., Li, N., & Wang, S. (2026) · Discover Oncology · doi:10.1007/s12672-026-05562-4 · Cited by 1
Epigenetics and One-Carbon Metabolism in Cancer: Mechanisms and Therapeutic Implications
Serpa, J., & Costa, J. R. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_9 · Cited by 1
Characterization of Top Hub Genes in Breast and Lung Cancer Using Functional Association
Makhijani, R., & Raut, S. (2019) · Advances in intelligent systems and computing · doi:10.1007/978-981-15-0184-5_42 · Cited by 1
Wahl, D. R., & Venneti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_6 · Cited by 1
Liao, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00005-1 · Cited by 1
Szwed, M., Sønstevold, T., Øverbye, A., Engedal, N., Grallert, B., Mørch, Y. A., Iversen, T., Skotland, T., Sandvig, K., & Torgersen, M. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/304618 · Cited by 1
Reversing Anoikis Resistance in Triple-Negative Breast Cancer
Richer, J. K. (2014) · doi:10.21236/ada613479 · Cited by 1
Dissecting the impact of metabolic environment on three common cancer cell phenotypesPreprint
Kochanowski, K., Sander, T., Link, H., Chang, J. B., Altschuler, S. J., & Wu, L. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.23.167437 · Cited by 1
Li, H., Zhang, F.-X., Huang, C., Liu, Q., Li, J., He, W., Zhang, X., Gao, J., Li, G., & Li, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3467320/v1 · Cited by 1
Bahnassy, S., Young, T., Abalum, T. C., Pope, E. A., Rivera, A. T., Fernandez, A. I., Olukoya, A. O., Mobin, D., Ranjit, S., Libbey, N. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.29.615681 · Cited by 1
ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis SensitivityPreprint
Kung, C.-P., Terzich, N., Ilagan, M. X. G., Prinsen, M. J., Kaushal, M., Kladney, R. D., Weber, J., Mabry, A., Torres, L. S., Bramel, E. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633410 · Cited by 1
The Role of Glutamine Synthetase in the Glutamine Independence in Mammary Tissue
Kung, H., & Chi, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_7
Residual breast cancer metabolic phenotype after docetaxel treatment
Volpari, T. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Venkatraman, B. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.192931
Tumor starvation by deprivation of glutamine and aspartate
Fried, R., Carlton, R. M., & Fried, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824013-7.00008-0
Construction of Reduced PPI Network for Breast and Lung Cancer Using Random Walk with Restart
Makhijani, R. (2021) · Lecture notes in networks and systems · doi:10.1007/978-981-33-4084-8_39
Wu, J., Liao, X., Wu, Q.-L., & Yu, W. (2021) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v29.i10.526
Glutamine metabolism in prostate cancer
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00001-1
Uma visão estrutural sobre componentes do processo de adaptação metabólica de tumores
Ambrosio, A. L. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2018.tde-25022021-104637
Sønstevold, T. (2021) · NORA - Norwegian Open Research Archives
Wibowo, A. (2014) · SKRIPSI Jurusan Teknik Mesin - Fakultas Teknik UM
Radiation-induced ternary copolymerization of vinyl fluoride, vinyl acetate, and acrylic acid
Usmanov, K. U., Yul'chibaev, A. A., & Aslanova, R. (1972) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Gleeson, P. A. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738812025.793585380
Selenoprotein Sepp1 regulates Cysteine Dependence in Pancreatic CancerPreprint
Amer, A., Alothaim, T., & Tang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1887450/v1
Biochemical mechanism of ferroptosis-mediated cancer cell death in triple-negative breast cancer
Chidamabaram, A., Thekkumalai, M., Prabasheela, B., Bhagat, T. S., Batra, J., & Dhandayuthapani, S. (2022) · Santosh University Journal of Health Sciences · doi:10.4103/sujhs.sujhs_37_22
The Roles of Iron and Ferroptosis in Human Chronic Diseases
Shi, Y., Zhang, J., Luo, K., Pan, S., Shi, H., Xiong, L., & Du, S. (2023) · Biochemistry · doi:10.5772/intechopen.108790
Greer, Y. E., Hernandez, L. F., Fennell, E. M. J., Kundu, M., Voeller, D. M., Chari, R., Gilbert, S. F., Gilbert, T. S. K., Ratnayake, S., Tang, B., et al. (2023) · doi:10.1158/2767-9764.22545575
Novel Aza-podophyllotoxin Derivative Inhibits Growth of Triple-Negative Breast Cancer
Dheeraj, A., Garcia-Marques, F. J., Chennai, B., Tailor, D., Bermudez, A., Grau, B. W., Haley, C. B., Pitteri, S. J., & Malhotra, S. V. (2025) · ACS Omega · doi:10.1021/acsomega.5c00052
Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution
Jin, Z., Li, H., Li, J., Chang, Y., Piao, Z., Jin, Q., & Jin, T. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112111
ELAVL1: A Novel Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma Linked to FerroptosisPreprint
Li, X. H., Hu, Y., Shao, B., & Wang, J. (2025) · medRxiv · doi:10.1101/2025.11.23.25340837
Ruiu, R., Cossu, C., Iacoviello, A., Conti, L., Bolli, E., Ponzone, L., Magri, J., Rumandla, A., Calautti, E., & Cavallo, F. (2024) · Figshare · doi:10.6084/m9.figshare.24217664
Jekabsons, M. B., Merrell, M., Skubiz, A. G., Thornton, N., Milasta, S., Green, D. R., Chen, T., Wang, Y.-H., Avula, B., Khan, I. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22615481
Ruiu, R., Cossu, C., Iacoviello, A., Conti, L., Bolli, E., Ponzone, L., Magri, J., Rumandla, A., Calautti, E., & Cavallo, F. (2023) · Figshare · doi:10.6084/m9.figshare.24217565
Additional file 1 of Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Yao, X., Xie, R., Cao, Y., Tang, J., Men, Y., Peng, H., & Yang, W. (2021) · Figshare · doi:10.6084/m9.figshare.16779591
Khadka, S., Arthur, K., Barekatain, Y., Behr, E., Washington, M., Ackroyd, J., Crowley, K., Suriyamongkol, P., Lin, Y.-H., Pham, C.-D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14850809
Li, Z., Wu, X., Wang, W., Gai, C., Zhang, W., Li, W., & Ding, D. (2021) · Figshare · doi:10.6084/m9.figshare.14100279
Disulfidptosis-based cancer therapy: Opportunity and challenge
Wang, B., Liu, Z., Li, J., Xu, J., Guo, Y., Zhang, J., Chu, T., Feng, Z., Jiang, Q., & Wu, D. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2025.102028 · Cited by 1
Cormerais, Y. (2016) · theses.fr (ABES) · doi:10.70675/94cc6971z3a1dz454fzb65dzf153dc0a3a05
Rôle de l'autophagie dans l'émergence des cellules souches cancéreuses : implication du métabolisme
El-Hout, M. (2019) · theses.fr (ABES) · doi:10.70675/881cf980z01caz4a56z8a81zdcebe1247536
Plant virus-derived nanoparticles for the imaging and treatment of cancer
Gamper, C. (2019) · theses.fr (ABES) · doi:10.70675/844eefddz7e34z4b59z978bzda1d6c32d297
Dragic, D. D. (2024) · theses.fr (ABES) · doi:10.70675/d181ac2eze69az40f6z8730zd4c0d9342686
Eldjoudi, A. N. (2023) · theses.fr (ABES) · doi:10.70675/690000f1zbe7dz4590zaa5fz92ff6ce464c8
Fu, Y., Liu, X., Sun, Q., Tang, Z., Xu, Z., & Liu, K. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04343-x
Damani, R. A., Hensley, C., Choi, H., Lee, H., Zhou, R., Pantel, A., Mankoff, D. A., & Li, E. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736194
Cho, M., & Song, M. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01798-w
Valproic acid inhibits glutamine uptake to induce ferroptosis in triple-negative breast cancer
Yang, Y., Liu, J., Liu, Y., Zou, T., Tao, R., Tan, X., & Liu, S. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112890
Shao, D., Song, J., & Wang, J. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103188
Amino acid transporters in hepatocellular carcinoma: Gatekeepers of metabolic reprogramming
Immanuel, J. R., Shankaran, Z. S., Mani, M., Paul, S. F. D., Ashok, B. S., Chand, L., & Walter, C. E. J. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12759-x
Choi, H. Y., Kwon, H., & Hah, Y. (2026) · Antioxidants · doi:10.3390/antiox15101223
Glutamine metabolism in health and disease
Zhao, J., Lin, Y., Gao, R., Gao, H., & Li, L. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02981-1
BindingDB (2021) · UC San Diego · doi:10.7270/q2ng4v40
BindingDB (2021) · UC San Diego · doi:10.7270/q2n87f26
Glutamine metabolic interaction network reshapes tumor immunotherapy resistance
Tang, S.-C., Liu, J.-X., Wang, Y., Wang, H., & Lu, L. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.10.001
Metadata
- Authors
- Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., Polyak, K., McCormick, F., & Gray, J. W.
- Affiliations
- University of California, San Francisco (US)
- San Francisco State University (US)
- Medical Research Council (GB)
- Novartis (China) (CN)
- Medical University of South Carolina (US)
- Oregon Health & Science University (US)
- Corresponding author
- Timmerman, Luika A.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 24
- Issue
- 4
- Pages
- 450-465
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3931310
- OpenAlex
- W2034530633
- Cited by
- 573
- References
- 61
- Citations by year
- 2026: 21 · 2025: 46 · 2024: 50 · 2023: 51 · 2022: 49 · 2021: 75 · 2020: 56 · 2019: 55 · 2018: 37 · 2017: 39 · 2016: 39 · 2015: 33 · 2014: 21
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- University of California, San Francisco
- National Cancer Institute (P50CA058207, U54CA112970)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- triple-negative breast cancer, glutamine addiction, glutamine uptake, sulfasalazine, therapeutic target, breast cancer cell lines, cancer metabolism, drug development
- MeSH terms
- Animals, Female, Glutamine, Glutathione, Humans, Prognosis, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Disease Progression, Gene Expression Profiling, Amino Acid Transport System y+, RNA, Small Interfering, Cell Line, Tumor, Mice, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review